Could Pulmatrix, Inc. (PULM) Change Direction After Touching 52 Week Low?

March 22, 2018 - By Louis Casey

The stock of Pulmatrix, Inc. (NASDAQ:PULM) hit a new 52-week low and has $1.08 target or 3.00 % below today’s $1.11 share price. The 7 months bearish chart indicates high risk for the $23.36 million company. The 1-year low was reported on Mar, 22 by If the $1.08 price target is reached, the company will be worth $700,890 less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock.

The stock decreased 1.77% or $0.02 during the last trading session, reaching $1.11. About 201,293 shares traded. Pulmatrix, Inc. (NASDAQ:PULM) has risen 15.00% since March 22, 2017 and is uptrending. It has underperformed by 1.70% the S&P500.

Pulmatrix, Inc., a clinical stage biopharmaceutical company, engages in developing inhaled therapies to address serious pulmonary diseases using its inhaled Small Particles Easily Respirable and Emitted technology. The company has market cap of $23.36 million. The company??s proprietary product pipeline focuses on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with cystic fibrosis, as well as PUR1500, an inhaled product for the treatment of idiopathic pulmonary fibrosis (IPF). It currently has negative earnings. It is also developing PUR0200, a branded generic in clinical development for chronic obstructive pulmonary disease.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.